Serial 99488645
Live / Allowed — Publication / registration review complete (as of 30 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 10 Nov 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99488645
- Mark type
- Design / logo
- Filed
- 10 Nov 2025
- Published for opposition
- 21 Apr 2026
- Attorney of record
- Elizabeth K. Rucki
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; Pharmaceutical preparations for the prevention of infectious diseases; Vaccines; Anti-infectives
Owner
- Glaxo Group Limited, Stevenage, GB
Prosecution history
- 23 Mar 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 20 Mar 2026 — ASSIGNED TO EXAMINER
- 19 Mar 2026 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 19 Mar 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 10 Nov 2025 — APPLICATION FILING RECEIPT MAILED
- 10 Nov 2025 — NEW APPLICATION ENTERED